tradingkey.logo

Enovis Corp

ENOV
31.240USD
+0.565+1.84%
Cierre 10/31, 16:00ETCotizaciones retrasadas 15 min
1.79BCap. mercado
PérdidaP/E TTM

Más Datos de Enovis Corp Compañía

Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment develops, manufactures, and distributes rigid bracing products, orthopedic soft goods, vascular systems and compression garments, and hot and cold therapy products and offers recovery sciences products in the clinical rehabilitation and sports medicine markets, such as bone growth stimulators and electrical stimulators used for pain management. The Reconstructive segment develops, manufactures, and markets a variety of knee, hip, shoulder, elbow, foot, ankle, and finger implant products and surgical productivity tools. It also provides Novastep, a minimally invasive surgery (MIS) foot and ankle solutions.

Información de Enovis Corp

Símbolo de cotizaciónENOV
Nombre de la empresaEnovis Corp
Fecha de salida a bolsaMay 08, 2008
Director ejecutivoMr. Damien Mcdonald
Número de empleados7367
Tipo de seguridadOrdinary Share
Fin del año fiscalMay 08
Dirección2711 Centerville Road
CiudadWILMINGTON
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal19808
Teléfono13022529160
Sitio Webhttps://www.enovis.com/
Símbolo de cotizaciónENOV
Fecha de salida a bolsaMay 08, 2008
Director ejecutivoMr. Damien Mcdonald

Ejecutivos de Enovis Corp

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Daniel Alexis Pryor
Mr. Daniel Alexis Pryor
Executive Vice President - Strategy and Business Development
Executive Vice President - Strategy and Business Development
114.51K
+9.57%
Mr. Damien Mcdonald
Mr. Damien Mcdonald
Chief Executive Officer, Director
Chief Executive Officer, Director
102.75K
+6.71%
Mr. Terry D. Ross
Mr. Terry D. Ross
Group President - Prevention and Recovery
Group President - Prevention and Recovery
35.79K
-0.90%
Ms. Sharon L. Wienbar
Ms. Sharon L. Wienbar
Independent Chairman of the Board
Independent Chairman of the Board
28.26K
+30.46%
Mr. Rajiv Vinnakota
Mr. Rajiv Vinnakota
Independent Director
Independent Director
20.37K
+47.89%
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Independent Director
Independent Director
15.27K
+76.12%
Ms. Barbara W. Bodem
Ms. Barbara W. Bodem
Independent Director
Independent Director
10.52K
+168.36%
Dr. Christine Ortiz, Ph.D.
Dr. Christine Ortiz, Ph.D.
Independent Director
Independent Director
10.52K
+168.36%
Mr. Philip A. Okala
Mr. Philip A. Okala
Independent Director
Independent Director
--
--
Ms. Angela S. Lalor
Ms. Angela S. Lalor
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Daniel Alexis Pryor
Mr. Daniel Alexis Pryor
Executive Vice President - Strategy and Business Development
Executive Vice President - Strategy and Business Development
114.51K
+9.57%
Mr. Damien Mcdonald
Mr. Damien Mcdonald
Chief Executive Officer, Director
Chief Executive Officer, Director
102.75K
+6.71%
Mr. Terry D. Ross
Mr. Terry D. Ross
Group President - Prevention and Recovery
Group President - Prevention and Recovery
35.79K
-0.90%
Ms. Sharon L. Wienbar
Ms. Sharon L. Wienbar
Independent Chairman of the Board
Independent Chairman of the Board
28.26K
+30.46%
Mr. Rajiv Vinnakota
Mr. Rajiv Vinnakota
Independent Director
Independent Director
20.37K
+47.89%
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Independent Director
Independent Director
15.27K
+76.12%

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por negocioUSD
Nombre
Ganancia
Proporción
International Reconstructive
144.48M
25.59%
U.S. Reconstructive
129.49M
22.94%
U.S. Bracing & Support
120.85M
21.41%
International P&R
98.90M
17.52%
U.S. Other P&R
70.82M
12.55%
Sin datos
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
International Reconstructive
144.48M
25.59%
U.S. Reconstructive
129.49M
22.94%
U.S. Bracing & Support
120.85M
21.41%
International P&R
98.90M
17.52%
U.S. Other P&R
70.82M
12.55%

Estadísticas de accionistas

Actualizado: mié., 22 de oct
Actualizado: mié., 22 de oct
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
14.03%
The Vanguard Group, Inc.
11.14%
American Century Investment Management, Inc.
8.29%
Dimensional Fund Advisors, L.P.
5.11%
Davenport Asset Management
4.91%
Otro
56.53%
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
14.03%
The Vanguard Group, Inc.
11.14%
American Century Investment Management, Inc.
8.29%
Dimensional Fund Advisors, L.P.
5.11%
Davenport Asset Management
4.91%
Otro
56.53%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
60.73%
Investment Advisor/Hedge Fund
37.03%
Hedge Fund
14.15%
Research Firm
5.59%
Individual Investor
1.59%
Bank and Trust
1.27%
Pension Fund
1.09%
Venture Capital
0.13%
Sovereign Wealth Fund
0.05%

Participación institucional

Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
636
68.64M
120.08%
-5.33M
2025Q2
641
62.33M
109.11%
-9.18M
2025Q1
646
68.39M
119.73%
-3.70M
2024Q4
637
64.20M
113.02%
-5.55M
2024Q3
613
62.53M
111.92%
-6.94M
2024Q2
617
64.91M
118.38%
-5.04M
2024Q1
651
62.70M
114.40%
-9.13M
2023Q4
661
61.64M
112.95%
-6.99M
2023Q3
653
60.52M
110.96%
-10.76M
2023Q2
641
59.95M
109.96%
-8.07M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
BlackRock Institutional Trust Company, N.A.
8.02M
14.03%
+1.50M
+22.95%
Jun 30, 2025
The Vanguard Group, Inc.
6.37M
11.14%
+288.04K
+4.74%
Jun 30, 2025
American Century Investment Management, Inc.
4.74M
8.29%
+1.21M
+34.39%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
2.92M
5.11%
-7.00K
-0.24%
Jun 30, 2025
Davenport Asset Management
2.76M
4.82%
-86.99K
-3.06%
Jul 31, 2025
Dorsey Asset Management LLC
2.55M
4.47%
+2.55M
--
Jun 30, 2025
State Street Investment Management (US)
2.49M
4.35%
+592.50K
+31.27%
Jun 30, 2025
Royce Investment Partners
2.42M
4.23%
-71.88K
-2.89%
Jun 30, 2025
Hood River Capital Management LLC
1.74M
3.04%
+292.95K
+20.31%
Jun 30, 2025
River Road Asset Management, LLC
1.44M
2.52%
+48.04K
+3.45%
Jun 30, 2025
Ver más

ETFs relacionados

Actualizado: hace 5 horas
Actualizado: hace 5 horas
Nombre
Proporción
SPDR S&P Health Care Equipment ETF
1.63%
Invesco S&P SmallCap Health Care ETF
1.1%
Invesco S&P SmallCap 600 Pure Value ETF
0.45%
SPDR S&P 600 Small Cap Value ETF
0.24%
iShares S&P Small-Cap 600 Value ETF
0.24%
iShares U.S. Medical Devices ETF
0.2%
Avantis US Small Cap Equity ETF
0.2%
Humankind US Stock ETF
0.19%
SPDR S&P SmallCap 600 ESG ETF
0.17%
Invesco S&P SmallCap 600 Revenue ETF
0.16%
Ver más
SPDR S&P Health Care Equipment ETF
Proporción1.63%
Invesco S&P SmallCap Health Care ETF
Proporción1.1%
Invesco S&P SmallCap 600 Pure Value ETF
Proporción0.45%
SPDR S&P 600 Small Cap Value ETF
Proporción0.24%
iShares S&P Small-Cap 600 Value ETF
Proporción0.24%
iShares U.S. Medical Devices ETF
Proporción0.2%
Avantis US Small Cap Equity ETF
Proporción0.2%
Humankind US Stock ETF
Proporción0.19%
SPDR S&P SmallCap 600 ESG ETF
Proporción0.17%
Invesco S&P SmallCap 600 Revenue ETF
Proporción0.16%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Tipo
Relación
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
Fecha
Tipo
Relación
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
KeyAI